Form 4: Stereotaxis Director Arun Menawat Receives Significant Restricted Stock Unit Grant

Stereotaxis, Inc. Director Arun Swarup Menawat was granted 43,668 restricted share units, increasing his beneficial ownership to 945,509 shares.

Summary

• Arun Swarup Menawat, a Director of Stereotaxis, Inc. (STXS), acquired 43,668 shares of common stock through a grant of restricted share units.
• The transaction date for this acquisition was July 1, 2025.
• The acquisition price for these restricted share units was $0 per unit.
• Following this transaction, Mr. Menawat's total beneficial ownership of Stereotaxis common stock increased to 945,509 shares.
• Each restricted share unit represents a right to receive one share of common stock.
• The restricted share units are subject to vesting conditions, which include the earliest of: the fifth anniversary of the award date, termination of the director's service on the board, or a Change of Control as defined in the award documents.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While it's not a direct cash investment, the grant of restricted stock units aligns the director's interests with shareholders and is a standard compensation practice, indicating continued commitment.

Positives

• The grant of restricted share units aligns the director's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• An increase in beneficial ownership by a director can signal confidence in the company's future prospects.

Negatives

• The acquisition price was $0, indicating a grant rather than a direct cash investment by the director.
• The shares are restricted and subject to vesting conditions, meaning they are not immediately liquid for the director.

Risks

• The value of the restricted share units is dependent on the future stock price of Stereotaxis, Inc., which could decline.
• Vesting conditions must be met for the director to fully realize the shares, including continued service or a change of control event.

Future Outlook

The grant of restricted share units indicates a long-term incentive for the director, aligning their future compensation with the company's performance and shareholder value creation over the next five years or until specific events occur.

Industry Context

Equity grants, such as restricted stock units, are a common form of compensation for directors and executives in publicly traded companies, particularly in the medical technology sector, to incentivize long-term performance and align interests with shareholders.

Comparison to Industry Standards

• The use of restricted stock units for director compensation is a standard practice across various industries, including medical technology, aligning with corporate governance best practices.
• The vesting conditions (time-based, service-based, or change of control) are typical for such equity awards, ensuring retention and incentivizing strategic outcomes.

Related Party Transactions

• Grant of 43,668 restricted share units to Director Arun Swarup Menawat, which represents a form of compensation and a related party transaction.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with the company's long-term performance, potentially benefiting shareholders if the stock price appreciates.
• Director (Arun Swarup Menawat): Receives equity compensation, incentivizing continued service and strategic contributions.

Next Steps

• The restricted share units will vest on the earliest of the fifth anniversary of the award date, termination of the director's service, or a Change of Control.

Key Dates

Keywords

Stereotaxis, STXS, Form 4, insider transaction, beneficial ownership, restricted stock units, RSU, director compensation, equity grant, corporate governance